Growth hormone treatment in non-growth hormone-deficient short children

S. Loche, M. R. Casini, G. M. Ubertini, M. Cappa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The unlimited availability of GH obtained by recombinant DNA technology has allowed optimization of treatment in GH-deficient (GHD) children. At the same time it has prompted a number of studies in conditions not characterized by GHD such as Turner syndrome, intrauterine growth retardation, chronic renal failure and other chromosomal and genetic abnormalities associated with short stature. Several controlled and uncontrolled studies have now reported the adult height of patients with short stature and normal GH secretion. Critical reviewing of the data shows that some short non-GHD children may benefit from a prolonged treatment with GH. However, further studies are needed in order to be able to identify the subjects for whom treatment is really beneficial.

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalJournal of Endocrinological Investigation
Volume28
Issue number2
Publication statusPublished - 2005

Fingerprint

Growth Hormone
Hormones
Turner Syndrome
Recombinant DNA
Fetal Growth Retardation
Chromosome Aberrations
Chronic Kidney Failure
Therapeutics
Technology

Keywords

  • Children
  • Growth hormone
  • Puberty
  • Short stature

ASJC Scopus subject areas

  • Endocrinology

Cite this

Growth hormone treatment in non-growth hormone-deficient short children. / Loche, S.; Casini, M. R.; Ubertini, G. M.; Cappa, M.

In: Journal of Endocrinological Investigation, Vol. 28, No. 2, 2005, p. 193-198.

Research output: Contribution to journalArticle

Loche, S. ; Casini, M. R. ; Ubertini, G. M. ; Cappa, M. / Growth hormone treatment in non-growth hormone-deficient short children. In: Journal of Endocrinological Investigation. 2005 ; Vol. 28, No. 2. pp. 193-198.
@article{55782858bec842bfb339ba25a3b900de,
title = "Growth hormone treatment in non-growth hormone-deficient short children",
abstract = "The unlimited availability of GH obtained by recombinant DNA technology has allowed optimization of treatment in GH-deficient (GHD) children. At the same time it has prompted a number of studies in conditions not characterized by GHD such as Turner syndrome, intrauterine growth retardation, chronic renal failure and other chromosomal and genetic abnormalities associated with short stature. Several controlled and uncontrolled studies have now reported the adult height of patients with short stature and normal GH secretion. Critical reviewing of the data shows that some short non-GHD children may benefit from a prolonged treatment with GH. However, further studies are needed in order to be able to identify the subjects for whom treatment is really beneficial.",
keywords = "Children, Growth hormone, Puberty, Short stature",
author = "S. Loche and Casini, {M. R.} and Ubertini, {G. M.} and M. Cappa",
year = "2005",
language = "English",
volume = "28",
pages = "193--198",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "2",

}

TY - JOUR

T1 - Growth hormone treatment in non-growth hormone-deficient short children

AU - Loche, S.

AU - Casini, M. R.

AU - Ubertini, G. M.

AU - Cappa, M.

PY - 2005

Y1 - 2005

N2 - The unlimited availability of GH obtained by recombinant DNA technology has allowed optimization of treatment in GH-deficient (GHD) children. At the same time it has prompted a number of studies in conditions not characterized by GHD such as Turner syndrome, intrauterine growth retardation, chronic renal failure and other chromosomal and genetic abnormalities associated with short stature. Several controlled and uncontrolled studies have now reported the adult height of patients with short stature and normal GH secretion. Critical reviewing of the data shows that some short non-GHD children may benefit from a prolonged treatment with GH. However, further studies are needed in order to be able to identify the subjects for whom treatment is really beneficial.

AB - The unlimited availability of GH obtained by recombinant DNA technology has allowed optimization of treatment in GH-deficient (GHD) children. At the same time it has prompted a number of studies in conditions not characterized by GHD such as Turner syndrome, intrauterine growth retardation, chronic renal failure and other chromosomal and genetic abnormalities associated with short stature. Several controlled and uncontrolled studies have now reported the adult height of patients with short stature and normal GH secretion. Critical reviewing of the data shows that some short non-GHD children may benefit from a prolonged treatment with GH. However, further studies are needed in order to be able to identify the subjects for whom treatment is really beneficial.

KW - Children

KW - Growth hormone

KW - Puberty

KW - Short stature

UR - http://www.scopus.com/inward/record.url?scp=20444457579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444457579&partnerID=8YFLogxK

M3 - Article

C2 - 15887870

AN - SCOPUS:20444457579

VL - 28

SP - 193

EP - 198

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 2

ER -